AU Stock MarketDetailed Quotes
RAD Radiopharm Theranostics Ltd
- 0.028
- -0.002-6.67%
20min DelayMarket Closed Nov 29 16:00 AET
60.84MMarket Cap-225P/E (Static)
0.031High0.028Low1.97MVolume0.031Open0.030Pre Close57.58KTurnover0.10052wk High0.13%Turnover Ratio2.17BShares0.02352wk Low-0.124EPS TTM43.78MFloat Cap0.495Historical HighLossP/E (Static)1.56BShs Float0.023Historical Low-0.124EPS LYR10.00%Amplitude--Dividend TTM2.15P/B1Lot Size--Div YieldTTM
About Radiopharm Theranostics Ltd Company
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.
Company Profile
SymbolRAD
Company NameRadiopharm Theranostics Ltd
Founded2021
MarketASX
Fiscal Year Ends06-30
Address62 Lygon Street Level 3, Carlton South
CityMelbourne
CountryAustralia
Zip Code3053
Phone+61 398245254
Share RegistryAUTOMIC REGISTRY SERVICES
Level 5, 126 Phillip Street, SYDNEY, NSW, AUSTRALIA, 2000
02 9698 5414
Company Executives
- Name
- Position
- Salary
- Paul Alex Hopper
- Executive Chairman,Founder,Executive Director
- --
- Riccardo Canevari
- Chief Executive Officer,Managing Director
- --
- Phillip Hains
- Chief Financial Officer,Joint Company Secretary,Non-executive Director
- --
- Ian Turner
- Non-Executive Director
- --
- Hester Larkin
- Non-Executive Director
- --
- Leila Alland
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data